Miller Capital Partners, Inc.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 2111377
TROY, MI
Position in VRTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$140,574
-$84,928 QoQ
Shares Held
283
-44.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,453
of 1,735 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Miller Capital Partners, Inc. holds $190,767 across 2 Biotechnology names. VRTX ranks #1 (73.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
283 | $140,574 | |
| 2 | SABS |
SAB Biotherapeutics, Inc.
|
12,870 | $50,193 |
All Filings in VRTX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $140,574 | 283 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $225,502 | 505 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $228,946 | 505 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||